.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Citi
Dow
Queensland Health
Harvard Business School
Baxter
Colorcon
UBS
Novartis
Covington
Johnson and Johnson

Generated: June 27, 2017

DrugPatentWatch Database Preview

Details for Patent: 6,117,894

« Back to Dashboard

Which drugs does patent 6,117,894 protect, and when does it expire?


Patent 6,117,894 protects ALINIA and is included in one NDA.

This patent has one hundred and twenty-three patent family members in forty-two countries.

Summary for Patent: 6,117,894

Title: Acid stabilized pharmaceutical compositions of tizoxanide and nitazoxanide
Abstract:The present invention relates to a pharmaceutical composition containing as active agent, solid particles of a compound selected from the group consisting of: compound of formula I: ##STR1## compound of formula II: ##STR2## and mixtures thereof. said particles having a particle size smaller than 200 .mu.m, the mean particle size of the said active solid particles being greater than 10 .mu.m. It also relates to a pharmaceutical composition which contains at least one pharmaceutically acceptable acid.
Inventor(s): Rossignol; Jean-Fran.cedilla.ois (Clearwater, FL)
Assignee: Romark Laboratories, L.C. (DE)
Application Number:09/073,436
Patent Claim Types:
see list of patent claims
Composition; Compound; Dosage form; Formulation; Process;

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Romark
ALINIA
nitazoxanide
FOR SUSPENSION;ORAL021498-001Nov 22, 2002RXYesYes6,117,894► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Patent: 6,117,894

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
5,859,038 Method for treatment of helicobacter pylori infections► Subscribe
5,965,590 Method for treatment of opportunistic infections with pharmaceutical compositions of tizoxanide and nitazoxanide► Subscribe
5,387,598 Composition and galenic formulation suitable for combatting affections of the lower abdomen► Subscribe
5,856,348 Method for treatment of trematodes with pharmaceutical compositions of tizoxanide and nitazoxanide► Subscribe
5,968,961 Pharmaceutical compositions of tizoxanide and nitazoxanide► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Patent: 6,117,894

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Slovenia20149► Subscribe
Russian Federation2140915► Subscribe
Serbia50046► Subscribe
Serbia20070379► Subscribe
Serbia49831► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Healthtrust
Merck
Baxter
Queensland Health
Harvard Business School
Federal Trade Commission
Medtronic
Johnson and Johnson
McKinsey
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot